Cinnarizine 25mg 50 tablets

Composition:
active ingredient: cinnarizine; 1 tablet contains cinnarizine 25 mg;
excipients: lactose, wheat starch, povidone K 25, colloidal silicon dioxide, magnesium stearate, microcrystalline cellulose.

Indications

Supportive treatment for symptoms of labyrinth disorders including dizziness, nausea, vomiting, tinnitus and nystagmus. Prevention of motion sickness. Prevention of migraine. Supportive treatment for symptoms of cerebrovascular origin, including dizziness, tinnitus (tinitis), headache of vascular origin, irritability, memory loss and inability to concentrate. Supportive care for symptoms of peripheral vascular disorders, including Raynaud’s disease, acrocyanosis, intermittent claudication, trophic disorders and varicose ulcers, paresthesias, nocturnal cramps in the extremities, sensation of coldness in the extremities

Dosage & Administration

Adults and children from 12 years. The tablets are taken orally after a meal, drinking plenty of water.
Symptomatic treatment of labyrinthine and vestibular disorders of vascular origin, Meniere’s disease. The daily dose is 75 mg (3 tablets), take 1 tablet, 3 times a day.

Prevention kinetoses. Take 1 tablet 2 hours before heading to the road and 1 tablet every 8 hours later in a travel.
Do not exceed the recommended dose.

The maximum daily dose for adults is 225 mg (9 tablets).
The effectiveness of treatment depends on the individual mode dose and sufficiently long duration of treatment.

Contradictions

Hypersensitivity to the active substance or to any component of the drug.

The drug is contraindicated during pregnancy and lactation.

Do not appy to children under the age of 12 years.